Cite
2021 American College of Rheumatology Guideline for the Treatment of Juvenile Idiopathic Arthritis: Recommendations for Nonpharmacologic Therapies, Medication Monitoring, Immunizations, and Imaging
MLA
Onel, Karen B., et al. “2021 American College of Rheumatology Guideline for the Treatment of Juvenile Idiopathic Arthritis: Recommendations for Nonpharmacologic Therapies, Medication Monitoring, Immunizations, and Imaging.” Arthritis Care and Research, vol. 74, no. 4, Apr. 2022, pp. 505–20. EBSCOhost, https://doi.org/10.1002/acr.24839.
APA
Onel, K. B., Horton, D. B., Lovell, D. J., Shenoi, S., Cuello, C. A., Angeles, H. S. T., Becker, M. L., Cron, R. Q., Feldman, B. M., Ferguson, P. J., Gewanter, H., Guzman, J., Kimura, Y., Lee, T., Murphy, K., Nigrovic, P. A., Ombrello, M. J., Rabinovich, C. E., Tesher, M., … Reston, J. T. (2022). 2021 American College of Rheumatology Guideline for the Treatment of Juvenile Idiopathic Arthritis: Recommendations for Nonpharmacologic Therapies, Medication Monitoring, Immunizations, and Imaging. Arthritis Care and Research, 74(4), 505–520. https://doi.org/10.1002/acr.24839
Chicago
Onel, Karen B., Daniel B. Horton, Daniel J. Lovell, Susan Shenoi, Carlos A. Cuello, Han, Sheila T. Angeles, Mara L. Becker, et al. 2022. “2021 American College of Rheumatology Guideline for the Treatment of Juvenile Idiopathic Arthritis: Recommendations for Nonpharmacologic Therapies, Medication Monitoring, Immunizations, and Imaging.” Arthritis Care and Research 74 (4): 505–20. doi:10.1002/acr.24839.